Daily PubMed evidence board
Systemic inflammatory response after robotic versus laparoscopic abdominal surgery: a systematic review and meta-analysis with colorectal cancer subgroup analysis.
This systematic review and meta-analysis pooled eight studies (including two randomized trials) comparing robotic and laparoscopic elective abdominal surg…
Signal score64Research triage score
CertaintyModerateVerify in full text
PMID42223505Source identifier
Research triage, not medical advice
Do not use this summary, score, or benefit-cost estimate to diagnose, treat, prescribe, or change care without reviewing the full study and consulting qualified professionals.
Verify before acting
Check full-text methods, eligibility, outcomes, risk of bias, harms, conflicts, funding, replication, and applicability.
Plain-English signal
This systematic review and meta-analysis pooled eight studies (including two randomized trials) comparing robotic and laparoscopic elective abdominal surgery, focusing on blood markers of inflammation. The authors report that C-reactive protein (CRP) on postoperative day 3 was significantly lower after robotic surgery overall, and the colorectal cancer subgroup showed an even larger reduction. Robotic surgery was also associated with fewer complications and non-significant trends toward less blood loss and shorter hospital stay, though operations were on average longer. The authors suggest robotic techniques may reduce tissue trauma and perioperative inflammation, which could matter for recovery and potentially long-term cancer outcomes, but the precise mechanisms and full clinical implications require review of the full text and further study.
Why it matters
- This meta-analysis compares postoperative biochemical markers of systemic inflammation (CRP, albumin, WCC) between robotic and laparoscopic colorectal/abdominal surgery, directly relevant to surgical approach decisions.
- The abstract reports a statistically significant lower postoperative day 3 CRP after robotic versus laparoscopic surgery overall and a larger effect in the colorectal cancer subgroup, which is relevant because lower perioperative inflammation has been associated with improved oncological outcomes.
- Secondary outcomes reported include a significantly lower overall complication rate with robotic surgery and trends toward reduced blood loss and shorter length of stay-outcomes that affect patient recovery, resource use, and perioperative planning.
Primary outcomes
- Postoperative biochemical markers of systemic inflammatory response (CRP, albumin, WCC) and clinically associated outcomes (complication rate, blood loss, length of stay).
Effect summary
Abstract-reported results: Postoperative day 3 CRP was significantly lower after robotic versus laparoscopic surgery (MD -13.18 mg/L overall; colorectal cancer subgroup MD -17.22 mg/L). Robotic surgery was associated with a significantly lower complication rate and non-significant trends toward reduced intraoperative blood loss and shorter length of hospital stay, but longer operative duration (mean +24 min).
Benefit-cost lens
| Quick take | Meta-analytic signal that robotic colorectal/abdominal surgery is associated with lower postoperative CRP and fewer complications versus laparoscopy; translating to policy or adoption requires local costs, baseline event rates, and implementation feasibility. |
|---|---|
| BCR anchor | 2 |
| Time horizon | 3 |
| Discount rate | 0.03 |
| Assumptions | Assessment based only on the abstract and PubMed metadata; full-text verification needed for extracted effect sizes, subgroup definitions, heterogeneity, risk-of-bias details, and costing assumptions. |
Benefit-cost fields are assumptions-based unless explicitly source-derived. Treat them as prompts for deeper economic review.
Risk of bias
| Tool | rapid-abstract-screen |
|---|---|
| Verdict | Some concerns |
| Notes | Assessment based on abstract: included studies comprise two RCTs and six observational cohorts; the abstract states an overall moderate risk of bias. No full-text RoB domains (randomization details, blinding, outcome assessment, selective reporting) were available in the abstract to permit a formal appraisal. |
Harms, equity, conflicts & implementation
| Implementation | Full-text review, extraction of absolute effect sizes and variances, local baseline outcome and cost data, assessment of surgeon experience and case mix, capital and operational cost estimation for robotic platforms, and stakeholder engagement. |
|---|---|
| Equity impact | Unclear from abstract; potential equity issues depend on local access to robotic platforms and referral patterns-full text should be checked for subgroup analyses by socioeconomic or demographic factors. |
| Harms | Harms are not detailed in the abstract beyond complication rates; longer operative duration with robotic surgery is reported and may have implications; full-text review needed for detailed adverse event profiles. |
| Registration | PROSPERO CRD420251167614 |
| Replication | Unknown from abstract-level triage; meta-analysis pooling reported but underlying study replication status requires full-text inspection. |
Source links — verify original
Use PubMed and full-text links to confirm methods, population, outcomes, harms, conflicts, and applicability.